COST-MINIMIZATION ANALYSIS (CMA) OF CANAGLIFLOZIN COMPARED TO GLIMEPIRIDE AND SITAGLIPTIN AS DUAL THERAPY IN COMBINATION WITH METFORMIN

被引:0
|
作者
Ravasio, R. [1 ]
Pisarra, P. [2 ]
Comaschi, M. [3 ]
机构
[1] Hlth Publishing & Serv, Milan, Italy
[2] Janssen Italy, Cologno Monzese, MI, Italy
[3] GVM Care & Res, ICLAS, Diabetol, Endocrinol,Med Interna, Genoa, Italy
关键词
D O I
10.1016/j.jval.2015.09.2111
中图分类号
F [经济];
学科分类号
02 ;
摘要
PDB72
引用
收藏
页码:A610 / A610
页数:1
相关论文
共 50 条
  • [41] Cost-minimization analysis of alemtuzumab compared to fingolimod and natalizumab for the treatment of active relapsing-remitting multiple sclerosis in the Netherlands
    Piena, M. A.
    Heisen, M.
    Wormhoudt, L. W.
    van Wingerden, J.
    Frequin, S. T. F. M.
    Uitdehaag, B. M. J.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (10) : 968 - 976
  • [42] Cost-minimization analysis (CMA) of capecitabine plus oxaliplatin (XELOX) compared with modified FOLFOX6 (mFOLFOX6) for the adjuvant treatment of resected colon cancer in British Columbia.
    Yunger, S.
    Mistry, B.
    Cheung, W. Y.
    Ksienski, D.
    Urspruch, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Cost-minimization analysis of DTaP-IPV-Hib combination vaccine in China: A nationwide cross-sectional study
    Liu, Bei
    Cao, Bing
    Wang, Chao
    Sun, Tao
    Miao, Yudong
    Zhang, Sihui
    Zhao, Tianshuo
    Cui, Fuqiang
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
  • [44] IS CANAGLIFLOZIN COST-EFFECTIVE COMPARED TO SITAGLIPTIN ACROSS MULTIPLE LINES OF TYPE 2 DIABETES MELLITUS (T2DM) THERAPY IN IRELAND?
    Bacon, T.
    Willis, M.
    Johansen, P.
    Neslusan, C.
    Nuhoho, S.
    Worbes-Cerezo, M.
    VALUE IN HEALTH, 2014, 17 (07) : A345 - A345
  • [45] Cost-minimization analysis of negative pressure wound therapy technologies for the treatment of moderate-to-severe foot infections
    Mallow, Peter J.
    Tepsick, Jon
    Davis, Kathryn E.
    Lavery, Lawrence A.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (14) : 1027 - 1033
  • [46] Peer review report 1 on "A cost-minimization analysis of first intention laparoscopic compared to open right hemicolectomy for colon cancer"
    Chesney, Tyler R.
    ANNALS OF MEDICINE AND SURGERY, 2016, 5 : S13 - S17
  • [47] COST-MINIMIZATION ANALYSIS OF TINZAPARIN SODIUM COMPARED TO OTHER LOW-MOLECULAR-WEIGHT HEPARINS FOR PATIENTS WITH DEEP VENOUS THROMBOSIS
    Diaz, J. P.
    Soto Molina, H.
    Marquez, M.
    Escobar Juarez, Y.
    VALUE IN HEALTH, 2015, 18 (03) : A143 - A143
  • [48] Cost-Minimization Analysis of Dexmedetomidine Compared to Other Sedatives for Short-Term Sedation During Mechanical Ventilation in the United States
    Aggarwal, Jyoti
    Lustrino, Jacqueline
    Stephens, Jennifer
    Morgenstern, Diana
    Tang, Wing Yu
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 389 - 397
  • [49] Economic evaluation of losartan compared with atenolol in the treatment of hypertension with left ventricular hypertrophy: Cost-minimization analysis based on LIFE study
    Chevreul, K
    Durand-Zaleski, I
    Souchet, T
    VALUE IN HEALTH, 2003, 6 (06) : 666 - 666
  • [50] Cost-minimization analysis in the Indian subcontinent for treating Guillain Barre Syndrome patients with therapeutic plasma exchange as compared to intravenous immunoglobulin
    Maheshwari, Ashish
    Sharma, Ratti R.
    Prinja, Shankar
    Hans, Rekha
    Modi, Manish
    Sharma, Navneet
    Marwaha, Neelam
    JOURNAL OF CLINICAL APHERESIS, 2018, 33 (06) : 631 - 637